Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02240238
Title	Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer
Recruitment	Completed
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	NanoCarrier Co., Ltd.
Indications	biliary tract cancer urethra transitional cell carcinoma lung squamous cell carcinoma cholangiocarcinoma ampulla of Vater carcinoma gallbladder cancer ureter transitional cell carcinoma bladder urothelial carcinoma renal pelvis transitional cell carcinoma Advanced Solid Tumor
Therapies	Gemcitabine + NC-6004
Age Groups:	senior \| adult
Covered Countries	USA \| ROU \| POL \| ITA \| BGR